The application of S-ketamine during endoscopy in children

Observational study of different dose of S-Ketamine combined with propofol during endoscopy in children

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034136

Enrollment

Unknown

Registered

2020-06-25

Start date

2020-06-15

Completion date

Unknown

Last updated

2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases requiring gastroscopy in children

Interventions

P Group:Propofol Group:Only propofol be used,without S-Ketamine

S1 Group:After applying propofol, S-Ketamine 0.5mg/kg be used.

S2 Group:After applying propofol, S-Ketamine 1mg/kg be used.

S3 Group:After applying propofol, S-Ketamine 1.5mg/kg be used.

Eligibility

Sex/Gender

All

Age

1 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 3-12 years; 2. Children with ASA (American Society of Anesthesiology) preoperative comprehensive condition grade <= grade II; 3. Children without abnormal airway; 4. Those children with normal digestive tract anatomy, no mechanical obstruction, etc. cause high risk of regurgitation and aspiration.

Exclusion criteria

Exclusion criteria: 1. Children with progressive gastric hemorrhage; 2. Obese children (BMI > 35kg / m2).

Design outcomes

Primary

Measure	Time frame
success rate of smooth endoscope insertion;	—

Secondary

Measure	Time frame
total doses of proppfol be used every group;	—

Countries

China

Contacts

Public ContactZhang Bin

Qilu Children's Hospital of Shandong University

binzhang1980@sina.com+86 18866115706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026